Adults aged over 50 with long term health conditions Other
Conditions
Interventions
Current interventions as of 03/11/2025:
There are two study arms, intervention and control. Each group will complete assessments at baseline, 3 and 6 months. The intervention group will receive the AM
Sponsors
University of Bedfordshire
Eligibility
Sex/Gender
All
Age
50 Years to 120 Years
Inclusion criteria
Inclusion criteria: Current inclusion criteria as of 03/11/2025: 1. Adults (=50 years) 2. Diagnosed with at least one long-term health condition 3. Prescribed a stable daily medication regime and not taking medication more than four times per day 4. Has physical and/or memory-related difficulties taking medication and/or self-reported low medication adherence 5. And /or unsuccessfully tried other compliance aids, such as dosette boxes, calendar clocks, blister packs or talking labels. 6. Have sufficient English language skills 7. The patient provides written informed consent Previous inclusion criteria: 1. Adults (=65 years) 2. Diagnosed with at least one long-term health condition 3. Prescribed a stable daily medication regime and not taking medication more than four times per day 4. Has physical and/or memory-related difficulties taking medication and/or self-reported low medication adherence 5. And /or unsuccessfully tried other compliance aids, such as dosette boxes, calendar clocks, blister packs or talking labels. 6. Have sufficient English language skills 7. The patient provides written informed consent
Exclusion criteria
Exclusion criteria: 1. Patients on cytotoxic medications (e.g. Methotrexate) 2. Clinically unsuitable medications or medications unsuitable for the AMD used (e.g., size, storage, administration method) 3. Variable medication regime (e.g. Warfarin) and/or taking medication more than four times per day 4. Patients who are already using an AMD or other similar electronic device. 5. Patients are not responsible for taking their own medications (e.g. carer administers medication). 6. The patient does not provide informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Medication Refill Adherence (MRA) at baseline, 3 and 6 months 2. Self-report adherence data at baseline, 3 and 6 months 3. Adherence data for the intervention group will also be determined by using the Pivotell Administration Centre at 3 and 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Quality of Life 12-item Short-Form Health Survey (SF-12) at baseline, 3 and 6 months 2. Morisky Medication Adherence Scale (MMAS-8) at baseline, 3 and 6 months 3. Self-report healthcare resource use data at baseline, 3 and 6 months | — |
Countries
England, United Kingdom
Contacts
Public ContactJodi Emma Wainwright
Outcome results
None listed